PDGFR Tyrosine Kinase Inhibitor VI, SU6668
CAS: 210644-62-5
Ref. 3D-KIA64462
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire | |
250mg | To inquire |
Product Information
- 1H-Pyrrole-3-propanoic acid, 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-
- 1H-Pyrrole-3-propanoic acid, 5-[(Z)-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- 3-(2,4-Dimethyl-5-((2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-1H-pyrrol-3-yl)propionic acid
- 3-(2,4-Dimethyl-5-(2-oxo-1,2-dihydroindol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid
- 5-((1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-propanoic acid
PDGFR Tyrosine Kinase Inhibitor VI (SU6668) is a chemical compound that inhibits the tyrosine kinase domain of the PDGFR. It has been shown to be effective in treating metastatic colorectal cancer, and has been approved for use in Japan. Due to its toxicity profile, SU6668 cannot be used for long periods of time. The most common side effects are diarrhea, nausea, vomiting, neutropenia, and anemia. The toxicities observed in animal studies include weight loss, hemoptysis, thrombocytopenia, alopecia, hepatotoxicity and myelosuppression.
Chemical properties
Technical inquiry about: 3D-KIA64462 PDGFR Tyrosine Kinase Inhibitor VI, SU6668
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.